Stock Alert: Paylocity Holding Corporation (NASDAQ:PCTY), Achillion Pharmaceuticals (NASDAQ:ACHN), Tableau Software (NYSE:DATA), ANI Pharmaceuticals (NASDAQ:ANIP), Territorial Bancorp Inc. (NASDAQ:TBNK)

Paylocity Holding Corporation (NASDAQ:PCTY), announced financial results for the second quarter of fiscal year 2015, which ended December 31, 2014. Total revenue was $34.3million, an increase of 44% from the second quarter of fiscal year 2014. Due to the calendar year-end holiday schedule, a number of clients processed an extra payroll in December, which we estimate resulted in a 2% increase in total revenue in the quarter. On Friday shares of Paylocity Holding Corporation (NASDAQ:PCTY) closed at $26.52. Company’s EPS growth for next 5 years is recorded as 30.00%.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at Leerink Global Healthcare Conference on Thursday, February 12, 2015 at 8:55 a.m. ET at the Waldorf Astoria Hotel in New York, NY. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) in last trading activity fell -2.35% to close at $10.82. Company weekly performance is -27.14% while its quarterly performance stands at 6.60%. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is -35.86% away from its 52 week high.

Tableau Software Inc. (NYSE:DATA) reported fourth quarter non-GAAP EPS of $0.42 after the bell Wednesday, up from $0.20 in the prior year period. The consensus estimate was for EPS of $0.11. On last trading day Tableau Software, Inc. (NYSE:DATA) fell -1.34% to close at $97.41. Its volatility for the week is 3.54% while volatility for the month is 3.88%. DATA’s sales growth for past 5 years was 77.50% and its EPS growth for past 5 years was 0.00%. Tableau Software, Inc. (NYSE:DATA) monthly performance is 16.80%.

On Feb. 3, ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) announced the promotion of David J. Sullivan, Ph.D. to the position of Vice President, Quality Operations. Dr. Sullivan joined ANI in April 2014 from Boston Scientific where he was responsible for cGMP laboratories, quality engineering, and systems. Prior to Dr. Sullivan’s nine years at Boston Scientific, he worked in quality operations for pharmaceutical firms, including Abbvie (formerly Solvay Pharmaceuticals) as a research scientist. Dr. Sullivan earned his Ph.D. in analytical chemistry and his B.S. in chemistry from South Dakota State University. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has 1.90% insider ownership while its institutional ownership stands at 75.50%. In last trading activity company’s stock closed at $55.31.

On Jan. 26, Territorial Bancorp Inc. (NASDAQ:TBNK) announces that its Board of Directors has approved a cash dividend on its common stock of $0.16 per share. The dividend is expected to be paid on February 23, 2015 to stockholders of record as of February 9, 2015. On last trading day Territorial Bancorp Inc. (NASDAQ:TBNK) fell -0.32% to close at $21.68. Its volatility for the week is 1.44% while volatility for the month is 1.39%. TBNK’s sales growth for past 5 years was -0.60% and its EPS growth for past 5 years was 14.40%. Territorial Bancorp Inc. (NASDAQ:TBNK) monthly performance is 2.22%.

Leave a Reply

Your email address will not be published. Required fields are marked *